4//SEC Filing
MORSE DANIEL E. 4
Accession 0001144204-18-014761
CIK 0001540159other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:23 PM ET
Size
14.2 KB
Accession
0001144204-18-014761
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Award
Share Option (Right to Buy)
2018-03-12+2,500→ 2,500 totalExercise: $0.84Exp: 2025-03-12→ Common Shares (2,500 underlying) - Sale
Common shares, without par value
2018-02-28$0.79/sh−7,000$5,530→ 14,866 total(indirect: By Spouse) - Sale
Common shares, without par value
2018-03-09$0.81/sh−7,000$5,635→ 7,866 total(indirect: By Spouse) - Sale
Common Shares, without par value
2018-02-22$0.78/sh−7,800$6,115→ 28,866 total(indirect: By Spouse) - Sale
Common shares, without par value
2018-02-26$0.79/sh−7,000$5,530→ 21,866 total(indirect: By Spouse) - Sale
Common shares, without par value
2018-03-12$0.80/sh−3,500$2,790→ 4,366 total(indirect: By Spouse)
Holdings
- 194,523
Common Shares, without par value
Footnotes (1)
- [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001621331
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 8:23 PM ET
- Size
- 14.2 KB